Celtere 120mg Injection is a crucial medication utilized in the management of specific medical conditions. Its active ingredient, Denosumab, is a human monoclonal antibody that works by inhibiting the activity of osteoclasts, cells responsible for bone resorption. By reducing bone breakdown, Celtere helps to increase bone density and strength, thereby reducing the risk of fractures and other bone-related complications.
Celtere 120mg Injection is indicated for the treatment of bone loss associated with certain cancers, such as bone metastases from solid tumors and multiple myeloma, as well as for osteoporosis in postmenopausal women at high risk of fracture. It is also used to prevent skeletal-related events in patients with advanced prostate cancer who are receiving androgen deprivation therapy.
The typical dosage and administration schedule for Celtere 120mg Injection will be determined by a healthcare professional based on the individual patient’s condition and response to treatment. Common side effects may include hypocalcemia, musculoskeletal pain, fatigue, and gastrointestinal disturbances. It is essential to inform your doctor about any pre-existing medical conditions, especially kidney problems or low calcium levels, before starting this medication. Proper storage conditions, typically at room temperature and protected from light, should be maintained as per the manufacturer’s instructions.
